Showing results (201-210 of 1,503) with videos related to
Sort By:
Pageof 151
The Lancet. Global Health|July 2, 2017
National incidence of traumatic fractures in China: a retrospective survey of 512 187 individualsWei Chen, Hongzhi Lv, Song Liu, et al.The Lancet. Global Health|April 15, 2023
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trialXiaoqiu Liu, Jennifer Thompson, Haiyan Dong, et al.The Lancet. Global Health|April 15, 2023
Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South AfricaMaria Ruperez, Kwame Shanaube, Linda Mureithi, et al.The Lancet. Global Health|April 15, 2023
Timing of seasonal influenza epidemics for 25 countries in Africa during 2010-19: a retrospective analysisLedor S Igboh, Katherine Roguski, Perrine Marcenac, et al.The Lancet. Global Health|April 15, 2023
Impact of proactive and reactive vaccination strategies for health-care workers against MERS-CoV: a mathematical modelling studyDaniel J Laydon, Simon Cauchemez, Wes R Hinsley, et al.The Lancet. Global Health|March 29, 2021
Operation Warp Speed: implications for global vaccine securityThe Lancet. Global Health|March 17, 2015
The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysisStéphane Verguet, Cindy L Gauvreau, Sujata Mishra, et al.The Lancet. Global Health|July 17, 2020
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling studyAlexandra B Hogan, Britta L Jewell, Ellie Sherrard-Smith, et al.The Lancet. Global Health|August 14, 2020
Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational studyAshish Kc, Rejina Gurung, Mary V Kinney, et al.The Lancet. Global Health|May 18, 2023
Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling studyJohn D Anderson, Karoun H Bagamian, Clint J Pecenka, et al.Pageof 151